ytterbium has been researched along with Neoplasms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (25.81) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 2 (6.45) | 29.6817 |
| 2010's | 13 (41.94) | 24.3611 |
| 2020's | 4 (12.90) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Huang, H; Mu, X; Wang, D; Wei, S; Zhou, L | 1 |
| Jie, X; Wei, W; Wu, M; Yang, H | 1 |
| Dovzhenko, AP; Enrichi, F; Gubaidullin, AT; Mustafina, AR; Nizameev, IR; Petrov, KA; Sapunova, AS; Tatarinov, DA; Voloshina, AD; Vomiero, A; Zairov, RR | 1 |
| Gao, C; Kwong, CHT; Lee, SMY; Li, Z; Lu, S; Sun, C; Wang, R; Yang, YW | 1 |
| Cao, J; Cheng, X; Du, L; Huang, P; Li, Q; Liu, Y; Sun, J; Zhang, C; Zhou, H | 1 |
| Dong, J; Du, X; Huang, X; Yan, H | 1 |
| El-Toni, AM; Hu, L; Li, Q; Li, X; Lu, L; Wang, C; Wang, P; Wang, W; Zhang, F; Zhao, M | 1 |
| Dong, L; Hao, LN; Li, F; Liu, K; Lu, Y; Qian, HS; Song, YH; Su, Y; Tao, W; Wu, YD; Xu, YJ; Yan, X; Yang, XZ; Zhou, W | 1 |
| Hamblin, MR | 1 |
| Chen, C; Gong, H; Xu, R; Yee, LK; Zhang, Y | 1 |
| Chen, YY; Dai, YL; Li, CX; Lin, J; Ma, PA; Wu, Y; Yang, DM | 1 |
| Chen, Y; Hou, Z; Huang, S; Li, C; Lin, J; Liu, B; Ma, P; Zhang, Y | 1 |
| Koch, B; Mishra, K; Prasad, R; Rai, M; Rai, SB; Singh, AK; Singh, SK | 1 |
| Emfietzoglou, D; Kyriakou, I; Šefl, M | 1 |
| Di, Y; Gao, H; Mao, C; Mi, C; Wang, M; Wu, X; Wu, Y; Xu, S; Xu, Z; Zhang, J | 1 |
| Cao, C; Mao, C; Mi, C; Tian, Z; Wang, Z; Xu, S | 1 |
| Chen, Q; Wei, Y; Wu, B; Xing, D; Zhou, A | 1 |
| Choi, CY; Jiang, FL; Koon, HK; Kwong, DW; Liu, Y; Mak, NK; Poon, CT; Wong, WK | 1 |
| Coles, IP; Dale, RG; Jones, B | 1 |
| Franke, WG; Gössel, J; Grundmann, A; Pöpel, U; Schmiedel, T; Schomäcker, K | 1 |
| Bergmann, R; Franke, WG; Johannsen, B; Kampf, G; Knop, G | 1 |
| Battista, JJ; Lazarescu, GR | 1 |
| Aime, S; Botta, M; Crich, SG; Garino, E; Giovenzana, G; Pagliarin, R; Palmisano, G; Sisti, M | 1 |
| Fateeva, MN; Zherbin, EA | 1 |
| Ando, A; Ando, I; Doishita, K; Hiraki, T; Sanada, S | 1 |
| Franke, WG; Jantsch, K; Kühne, A; Rockstroh, K | 1 |
| Hiraki, T; Hisada, K; Sano, H; Suzaki, K; Suzuki, Y | 1 |
| Chatal, JF; Guihard, RD; Mevel, BP; Moigneteau, C | 1 |
| Hareyama, M; Moriya, H; Sakurai, T; Suekuni, M; Suzaki, K | 1 |
| Ando, A; Hiraki, T; Hisada, K | 1 |
| Ando, A; Hiraki, T; Hisada, K; Tonami, N | 1 |
31 other study(ies) available for ytterbium and Neoplasms
| Article | Year |
|---|---|
Polycyclodextrin as a linker for nanomedicine fabrication and synergistic anticancer application.
Topics: Adamantane; Animals; Antineoplastic Agents; Cyclodextrins; Female; Ferrocyanides; HeLa Cells; Humans; Isoindoles; Light; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Neoplasms; Organometallic Compounds; Photosensitizing Agents; Polymers; Reactive Oxygen Species; Ytterbium; Zinc Compounds | 2021 |
Red-Near-Infrared Fluorescent Probe for Time-Resolved in Vivo Alkaline Phosphatase Detection with the Assistance of a Photoresponsive Nanocontainer.
Topics: Acetaminophen; Alkaline Phosphatase; Animals; Benzopyrans; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Female; Fluorescent Dyes; Humans; Metal Nanoparticles; Mice, Inbred BALB C; Neoplasms; Optical Imaging; Thulium; Ytterbium; Yttrium | 2019 |
Dual red-NIR luminescent EuYb heterolanthanide nanoparticles as promising basis for cellular imaging and sensing.
Topics: Antineoplastic Agents; Cytotoxins; Europium; HeLa Cells; Humans; Luminescence; Metal Nanoparticles; Neoplasms; Ytterbium | 2019 |
Selective Decoating-Induced Activation of Supramolecularly Coated Toxic Nanoparticles for Multiple Applications.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Bridged-Ring Compounds; Cell Line, Tumor; Escherichia coli; Female; Fluorides; Gadolinium; Hyaluronic Acid; Imidazoles; Infrared Rays; Mice, Inbred C57BL; Microbial Sensitivity Tests; Nanoparticles; Neoplasms; Paraquat; Polyesters; Staphylococcal Infections; Staphylococcus aureus; Thulium; Ytterbium; Zebrafish | 2020 |
A Janus upconverting nanoplatform with biodegradability for glutathione depletion, near-infrared light induced photodynamic therapy and accelerated excretion.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chlorophyllides; Erbium; Female; Fluorides; Glutathione; Humans; Infrared Rays; Mice, Inbred BALB C; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Silicon Dioxide; Singlet Oxygen; Ytterbium; Yttrium | 2020 |
Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy.
Topics: Animals; Antineoplastic Agents; Cattle; Doxorubicin; Drug Carriers; Drug Liberation; Erbium; Female; Fluorides; Glutathione; HeLa Cells; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Metal Nanoparticles; Mice, Inbred C57BL; Myoglobin; Neoplasms; Porosity; Serum Albumin, Bovine; Silicon Dioxide; Xenograft Model Antitumor Assays; Ytterbium; Yttrium | 2021 |
Kinetics-mediate fabrication of multi-model bioimaging lanthanide nanoplates with controllable surface roughness for blood brain barrier transportation.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Cell Line; Female; Fluorides; Kinetics; Lanthanoid Series Elements; Luminescent Measurements; Magnetic Resonance Imaging; Mice, Inbred BALB C; Nanostructures; Neodymium; Neoplasms; Optical Imaging; Permeability; Surface Properties; Ytterbium; Yttrium | 2017 |
Sequential growth of CaF
Topics: Animals; Contrast Media; Gadolinium; HeLa Cells; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Ytterbium | 2017 |
Upconversion in photodynamic therapy: plumbing the depths.
Topics: Animals; Cell Line, Tumor; Erbium; Fluorescence Resonance Energy Transfer; Fluorides; Humans; Infrared Rays; Light; Mice; Nanoparticles; Neoplasms; Oxygen; Photochemotherapy; Photons; Photosensitizing Agents; Reactive Oxygen Species; Thulium; Xenograft Model Antitumor Assays; Ytterbium; Yttrium | 2018 |
A facile synthesis of strong near infrared fluorescent layered double hydroxide nanovehicles with an anticancer drug for tumor optical imaging and therapy.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Membrane; Drug Carriers; Erbium; Fluorescence; Fluorouracil; Humans; Hydroxides; Nanoparticles; Neoplasms; Tomography, Optical; Ytterbium; Yttrium | 2013 |
Multifunctional core-shell structured nanocarriers for synchronous tumor diagnosis and treatment in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Contrast Media; Doxorubicin; Drug Carriers; Erbium; Fluorides; Gadolinium; HeLa Cells; Humans; Magnetic Resonance Imaging; Magnetics; Mice; Nanocomposites; Nanoparticles; Neoplasms; Polyethylene Glycols; Porosity; Ytterbium | 2014 |
Multifunctional NaYF4:Yb, Er@mSiO2@Fe3O4-PEG nanoparticles for UCL/MR bioimaging and magnetically targeted drug delivery.
Topics: Animals; Antibiotics, Antineoplastic; Biocompatible Materials; Cell Survival; Contrast Media; Doxorubicin; Drug Carriers; Erbium; Female; Ferrosoferric Oxide; Fluorides; HeLa Cells; Humans; Magnetic Resonance Imaging; Magnetics; Mice; Nanoparticles; Neoplasms; Polyethylene Glycols; Silicon Dioxide; Tissue Distribution; Ytterbium; Yttrium | 2015 |
Enhanced red upconversion emission, magnetoluminescent behavior, and bioimaging application of NaSc0.75Er0.02Yb0.18Gd0.05F4@AuNPs nanoparticles.
Topics: Cell Line, Tumor; Gadolinium; Gold; HeLa Cells; Humans; Luminescence; Molecular Imaging; Nanoparticles; Neoplasms; Particle Size; Ytterbium; Yttrium | 2015 |
Technical Note: Impact of cell repopulation and radionuclide uptake phase on cell survival.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Radiation; Iodine Radioisotopes; Models, Biological; Neoplasms; Phosphorus Radioisotopes; Radiopharmaceuticals; Survival Analysis; Ytterbium | 2016 |
Multifunctional nanocomposites of superparamagnetic (Fe3O4) and NIR-responsive rare earth-doped up-conversion fluorescent (NaYF4 : Yb,Er) nanoparticles and their applications in biolabeling and fluorescent imaging of cancer cells.
Topics: Erbium; Ferrosoferric Oxide; Fluorescent Dyes; Fluorides; HeLa Cells; Humans; Magnetics; Metal Nanoparticles; Metals, Rare Earth; Microscopy, Fluorescence; Neoplasms; Spectrophotometry, Infrared; Ytterbium; Yttrium | 2010 |
Novel microwave-assisted solvothermal synthesis of NaYF4:Yb,Er upconversion nanoparticles and their application in cancer cell imaging.
Topics: Erbium; Fluorides; HeLa Cells; Humans; Microwaves; Nanoparticles; Neoplasms; Particle Size; Surface Properties; Temperature; Ytterbium; Yttrium | 2011 |
High-sensitivity in vivo imaging for tumors using a spectral up-conversion nanoparticle NaYF4: Yb3+, Er3+ in cooperation with a microtubulin inhibitor.
Topics: Animals; Diagnostic Imaging; Erbium; Fluorescent Dyes; Fluorides; Folic Acid; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Microtubules; Nanoparticles; Neoplasms; Signal-To-Noise Ratio; Stilbenes; Tubulin Modulators; Ytterbium; Yttrium | 2012 |
An amphiphilic bisporphyrin and its Yb(III) complex: development of a bifunctional photodynamic therapeutic and near-infrared tumor-imaging agent.
Topics: Animals; Cell Line, Tumor; Contrast Media; Diagnostic Imaging; Infrared Rays; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Ytterbium | 2008 |
Effect of tumour shrinkage on the biological effectiveness of permanent brachytherapy implants.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Gold Radioisotopes; Half-Life; Humans; Iodine Radioisotopes; Neoplasms; Palladium; Radioisotopes; Radiotherapy Dosage; Treatment Outcome; Ytterbium | 1994 |
[Initial results in tumor diagnosis with radioactive lanthanide complexes].
Topics: Colorectal Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Metals, Rare Earth; Neoplasms; Radioisotopes; Stomach Neoplasms; Tomography, Emission-Computed, Single-Photon; Ytterbium | 1993 |
Uptake of 169Yb complexes in normal and tumour cells: influence of ligand and metabolic cell activity and stability of cellular association.
Topics: Animals; Cell Line; Cricetinae; Humans; Ligands; Neoplasms; Radioisotopes; Temperature; Ytterbium | 1997 |
Analysis of the radiobiology of ytterbium-169 and iodine-125 permanent brachytherapy implants.
Topics: Biophysical Phenomena; Biophysics; Brachytherapy; Cell Death; Cell Division; Half-Life; Humans; Iodine Radioisotopes; Neoplasms; Radiobiology; Radioisotopes; Relative Biological Effectiveness; Ytterbium | 1997 |
Non-covalent conjugates between cationic polyamino acids and GdIII chelates: a route for seeking accumulation of MRI-contrast agents at tumor targeting sites.
Topics: Chelating Agents; Contrast Media; Europium; Gadolinium; Ligands; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Metals, Rare Earth; Neoplasms; Peptides; Polyamines; Polyelectrolytes; Static Electricity; Water; Ytterbium | 2000 |
[Achievements and perspectives of radioisotope diagnosis of malignant tumors (according to materials in the "Journal of Nuclear Medicine", 1974)].
Topics: Actinoid Series Elements; Animals; Antigens, Neoplasm; Bleomycin; Breast Neoplasms; Female; Gallium Radioisotopes; Humans; Indium; Iodine Radioisotopes; Isotope Labeling; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Metals, Rare Earth; Methionine; Mice; Neoplasms; Radioisotopes; Radionuclide Imaging; Selenium; Technetium; Ytterbium | 1976 |
Study of distribution of 169Yb, 67Ga and 111In in tumor tissue by macroautoradiography--comparison between viable tumor tissue and inflammatory infiltration around tumor.
Topics: Animals; Autoradiography; Carcinoma, Ehrlich Tumor; Connective Tissue; Gallium Radioisotopes; Indium; Neoplasms; Radioisotopes; Rats; Sarcoma, Yoshida; Ytterbium | 1977 |
[169 Yb citrate for tumour scintigraphy - first experiences (author's transl)].
Topics: Aged; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Radioisotopes; Radionuclide Imaging; Ytterbium | 1976 |
Clinical evaluation of tumor scanning with 169-Yb-citrate.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Barium Sulfate; Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; False Positive Reactions; Head and Neck Neoplasms; Hodgkin Disease; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Radiography; Radioisotopes; Radionuclide Imaging; Ytterbium | 1975 |
[Diagnostic value of ytterbium 169 citrate in cancerology].
Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Bronchial Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Ytterbium | 1975 |
[Clinical evaluation of the tumor scanning].
Topics: Aged; Citrates; Female; Gallium; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Radionuclide Imaging; Uterine Cervical Neoplasms; Ytterbium | 1974 |
[Radioisotope scanning of tumors with 169Yb-citrate].
Topics: Adolescent; Adult; Aged; Citrates; Female; Gallium; Humans; Leiomyosarcoma; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms; Radioisotopes; Radionuclide Imaging; Uterine Neoplasms; Ytterbium | 1973 |
Tumor scanning with 169Yb-citrate.
Topics: Bone Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Radioisotopes; Radionuclide Imaging; Ytterbium | 1973 |